Header Logo

LOUIS L PISTERS

TitleProfessor
InstitutionMD Anderson
DepartmentUrology
Address1155 Pressler St
Houston TX 77030-3721
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Anselmino N, Labanca E, Shepherd PDA, Dong J, Yang J, Song X, Nandakumar S, Kundra R, Lee CJ, Schultz N, Zhang J, Araujo JC, Aparicio AM, Subudhi SK, Corn PG, Pisters LL, Ward JF, Davis JW, Vazquez ES, Gueron G, Logothetis CJ, Futreal A, Troncoso P, Chen Y, Navone NM. Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series. Clin Cancer Res. 2024 Mar 15. PMID: 38488813.
      Citations:    Fields:    
    2. Gregg JR, Magill R, Fang AM, Chapin BF, Davis JW, Adibi M, Ch?ry L, Papadopoulos J, Pettaway C, Pisters L, Ward JF, Hahn AW, Daniel CR, Bhaskaran J, Zhu K, Guerrero M, Zhang M, Troncoso P. The association of body mass index with tumor aggression among men undergoing radical prostatectomy. Urol Oncol. 2024 04; 42(4):116.e1-116.e7. PMID: 38262868.
      Citations:    Fields:    Translation:Humans
    3. Singh J, Wang L, Smith TG, Graber W, Matin S, Pisters L, Lenaine Westney O. Ileal Interposition for Ureteral Reconstruction Following Treatment for Abdominopelvic Malignancy: Complications and Outcomes From a Comprehensive Cancer Center. Urology. 2024 Jan; 183:215-220. PMID: 37802194.
      Citations:    Fields:    Translation:Humans
    4. Dimitropoulos K, Pisters LL, Papandreou CN, Daliani D, Karatzas A, Petsiti A, Tassoudis V, Arnaoutoglou E, Vlachostergios PJ, Tzortzis V. The Impact of Enhanced Recovery after Surgery Protocol Implementation on Postoperative Pain Management in the Era of Opioid Crisis: The Postchemotherapy Open RPLND Experience. Curr Cancer Drug Targets. 2023; 23(11):910-916. PMID: 37170984.
      Citations:    Fields:    
    5. Tu SM, Singh SR, Arnaoutakis K, Malapati S, Bhatti SA, Joon AY, Atiq OT, Pisters LL. Stem Cell Theory of Cancer: Implications for Translational Research from Bedside to Bench. Cancers (Basel). 2022 Jul 09; 14(14). PMID: 35884406; PMCID: PMC9321703.
      Citations:    
    6. Tu SM, Pisters LL. Stem-Cell Theory of Cancer: Implications for Antiaging and Anticancer Strategies. Cancers (Basel). 2022 Mar 04; 14(5). PMID: 35267646; PMCID: PMC8909197.
      Citations:    
    7. Westerman ME, Yevich SM, Dori Y, Ward JF, Pisters LL, Karam JA, Wood CG, Avritscher R, Matin SF. Lymphangioembolization for iatrogenic chylous ascites after retroperitoneal urological surgery. BJU Int. 2022 05; 129(5):585-587. PMID: 34962705.
      Citations:    Fields:    Translation:Humans
    8. Moore JA, Slack RS, Lehner MJ, Campbell MT, Shah AY, Zhang M, Guo CC, Ward JF, Karam JA, Wood CG, Pisters LL, Tu SM. Very Late Recurrence in Germ Cell Tumor of the Testis: Lessons and Implications. Cancers (Basel). 2022 Feb 23; 14(5). PMID: 35267435; PMCID: PMC8909729.
      Citations:    
    9. Hwang MJ, Hamza A, Zhang M, Tu SM, Pisters LL, Czerniak B, Guo CC. Somatic-type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases. Am J Surg Pathol. 2022 01 01; 46(1):11-17. PMID: 34334690; PMCID: PMC8671201.
      Citations: 1     Fields:    Translation:Humans
    10. Asaad M, Pisters LL, Klein GT, Adelman DM, Oates SD, Butler CE, Selber JC. Robotic Rectus Abdominis Muscle Flap following Robotic Extirpative Surgery. Plast Reconstr Surg. 2021 Dec 01; 148(6):1377-1381. PMID: 34847128.
      Citations: 1     Fields:    Translation:Humans
    11. Alhalabi O, Campbell MT, Xiao L, Adriazola AC, Wilson NR, Siefker-Radtke AO, Corn PG, Zurita A, Jonasch E, Gao J, Adibi M, Kamat AM, Navai N, Pisters LL, Dinney C, Matin SF, Shah AY. Multimodal kidney-preserving approach in localised and locally advanced high-risk upper tract urothelial carcinoma. BJUI Compass. 2022 Jan; 3(1):37-44. PMID: 35475152; PMCID: PMC8988842.
      Citations: 2     
    12. Tu SM, Zhang M, Wood CG, Pisters LL. Stem Cell Theory of Cancer: Origin of Tumor Heterogeneity and Plasticity. Cancers (Basel). 2021 Aug 09; 13(16). PMID: 34439162; PMCID: PMC8394880.
      Citations: 4     
    13. Pisters PW, Ranasinghe W, Wei W, Wood CG, Matin SF, Ward JF, Pisters LL. Long-term renal functional outcomes following ureteroureterostomy performed during multi-organ resection for non-urothelial cancers. BJUI Compass. 2021 Sep; 2(5):348-354. PMID: 35474874; PMCID: PMC8988638.
      Citations: 2     
    14. Chin JL, Lavi A, Metcalfe MJ, Siddiqui K, Dewar M, Petros FG, Li R, Wang X, Nair SM, Ward JF, Pisters L, Nogueras Gonz?lez GM. Long-Term Outcomes of Whole Gland Salvage Cryotherapy for Locally Recurrent Prostate Cancer following Radiation Therapy: A Combined Analysis of Two Centers. J Urol. 2021 09; 206(3):646-654. PMID: 33908799.
      Citations:    Fields:    Translation:Humans
    15. Ranasinghe W, Shapiro DD, Zhang M, Bathala T, Navone N, Thompson TC, Broom B, Aparicio A, Tu SM, Tang C, Davis JW, Pisters L, Chapin BF. Optimizing the diagnosis and management of ductal prostate cancer. Nat Rev Urol. 2021 06; 18(6):337-358. PMID: 33824525.
      Citations: 3     Fields:    Translation:Humans
    16. Tu SM, Pisters LL. Curing Cancer: Lessons from a Prototype. Cancers (Basel). 2021 Feb 07; 13(4). PMID: 33562202; PMCID: PMC7915721.
      Citations: 1     
    17. Gregg JR, Borregales LD, Choi H, Lozano M, McRae SE, Venkatesan AM, Davis JW, Nogueras-Gonzalez GM, Pisters LL, Ward JF. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World J Urol. 2021 Sep; 39(9):3259-3264. PMID: 33454813; PMCID: PMC9810085.
      Citations:    Fields:    Translation:Humans
    18. Umbreit EC, Siddiqui BA, Hwang MJ, Joon AY, Maity T, Westerman ME, Merriman KW, Alhasson H, Uthup J, Guo T, Moore JA, Ward JF, Karam JA, Wood CG, Pisters LL, Zhang M, Tu SM. Origin of Subsequent Malignant Neoplasms in Patients with History of Testicular Germ Cell Tumor. Cancers (Basel). 2020 Dec 14; 12(12). PMID: 33327406; PMCID: PMC7764868.
      Citations: 8     
    19. Ranasinghe W, Shapiro DD, Hwang H, Wang X, Reichard CA, Elsheshtawi M, Achim MF, Bathala T, Tang C, Aparicio A, Tu SM, Navone N, Thompson TC, Pisters L, Troncoso P, Davis JW, Chapin BF. Ductal Prostate Cancers Demonstrate Poor Outcomes with Conventional Therapies. Eur Urol. 2021 02; 79(2):298-306. PMID: 33279304.
      Citations: 4     Fields:    Translation:Humans
    20. Umbreit EC, McIntosh AG, Suk-Ouichai C, Segarra LA, Holland LC, Fellman BM, Williams SB, Thomas AZ, Tu SM, Pettaway CA, Pisters LL, Ward JF, Wood CG, Karam JA. Intraoperative and early postoperative complications in postchemotherapy retroperitoneal lymphadenectomy among patients with germ cell tumors using validated grading classifications. Cancer. 2020 11 15; 126(22):4878-4885. PMID: 32940929; PMCID: PMC9379780.
      Citations: 1     Fields:    Translation:Humans
    21. Palanisamy N, Yang J, Shepherd PDA, Li-Ning-Tapia EM, Labanca E, Manyam GC, Ravoori MK, Kundra V, Araujo JC, Efstathiou E, Pisters LL, Wan X, Wang X, Vazquez ES, Aparicio AM, Carskadon SL, Tomlins SA, Kunju LP, Chinnaiyan AM, Broom BM, Logothetis CJ, Troncoso P, Navone NM. The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development. Clin Cancer Res. 2020 09 15; 26(18):4933-4946. PMID: 32576626; PMCID: PMC7501166.
      Citations: 18     Fields:    Translation:HumansAnimalsCells
    22. Ranasinghe WKB, Brooks NA, Elsheshtawi MA, Davis JW, Bathala TK, Tang C, Troncoso P, Aparicio A, Tu SM, Pisters LL, Chapin BF. Patterns of metastases of prostatic ductal adenocarcinoma. Cancer. 2020 08 15; 126(16):3667-3673. PMID: 32453443.
      Citations: 4     Fields:    Translation:Humans
    23. Subudhi SK, Vence L, Zhao H, Blando J, Yadav SS, Xiong Q, Reuben A, Aparicio A, Corn PG, Chapin BF, Pisters LL, Troncoso P, Tidwell RS, Thall P, Wu CJ, Zhang J, Logothetis CL, Futreal A, Allison JP, Sharma P. Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer. Sci Transl Med. 2020 04 01; 12(537). PMID: 32238575.
      Citations: 46     Fields:    Translation:HumansCellsCTClinical Trials
    24. Narayan VM, Seif MA, Lim AH, Li R, Matulay JT, Kukreja JB, Qiao W, Hwang H, Shah JB, Pisters L, Kamat AM, Dinney C, Navai N. Radical cystectomy in women: Impact of the robot-assisted versus open approach on surgical outcomes. Urol Oncol. 2020 04; 38(4):247-254. PMID: 31953001.
      Citations: 1     Fields:    Translation:Humans
    25. Siddiqui BA, Zhang M, Pisters LL, Tu SM. Systemic therapy for primary and extragonadal germ cell tumors: prognosis and nuances of treatment. Transl Androl Urol. 2020 Jan; 9(Suppl 1):S56-S65. PMID: 32055486; PMCID: PMC6995840.
      Citations: 3     
    26. Gregg JR, Davis JW, Reichard C, Wang X, Achim M, Chapin BF, Pisters L, Pettaway C, Ward JF, Choi S, Nguyen QN, Kuban D, Babaian R, Troncoso P, Madsen LT, Logothetis C, Kim J. Determining Clinically Based Factors Associated With Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort. Urology. 2020 04; 138:91-97. PMID: 31899230; PMCID: PMC7141963.
      Citations: 2     Fields:    Translation:Humans
    27. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, Kuban DA. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer. 2020 02 01; 126(3):506-514. PMID: 31742674; PMCID: PMC6980273.
      Citations: 7     Fields:    Translation:Humans
    28. Ho L, Pisters L, Tu SM. Rapidly enlarging abdominal mass in a patient with recurrent germ cell tumor. Clin Case Rep. 2019 Nov; 7(11):2285-2286. PMID: 31788307; PMCID: PMC6878095.
      Citations:    
    29. Efstathiou E, Davis JW, Pisters L, Li W, Wen S, McMullin RP, Gormley M, Ricci D, Titus M, Hoang A, Zurita AJ, Tran N, Peng W, Kheoh T, Molina A, Troncoso P, Logothetis CJ. Clinical and Biological Characterisation of Localised High-risk Prostate Cancer: Results of a Randomised Preoperative Study of a Luteinising Hormone-releasing Hormone Agonist with or Without Abiraterone Acetate plus Prednisone. Eur Urol. 2019 10; 76(4):418-424. PMID: 31176622; PMCID: PMC7205516.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    30. Valerio M, Emberton M, Heidenreich A, Crook JM, Bossi A, Pisters LL, Marra G. Salvage Local Treatments After Focal Therapy for Prostate Cancer. Eur Urol Oncol. 2019 09; 2(5):526-538. PMID: 31412013.
      Citations: 9     Fields:    Translation:Humans
    31. Li R, Kukreja JEB, Seif MA, Petros FG, Campbell MT, Nguyen JV, Kamat AM, Pisters LL, Dinney CP, Navai N, Gonz?lez GMN. The role of metastatic burden in cytoreductive/consolidative radical cystectomy. World J Urol. 2019 Dec; 37(12):2691-2698. PMID: 30864005.
      Citations: 4     Fields:    Translation:Humans
    32. Altok M, Kim B, Patel BB, Shih YT, Ward JF, McRae SE, Chapin BF, Pisters LL, Pettaway CA, Kim J, Demirel HC, Davis JW. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis. 2018 11; 21(4):524-532. PMID: 29988098.
      Citations: 13     Fields:    Translation:Humans
    33. Chahoud J, Zhang M, Pisters LL, Lin SC, Lin SH, Tu SM. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors. Clin Genitourin Cancer. 2018 10; 16(5):325-327. PMID: 29807831.
      Citations: 1     Fields:    Translation:HumansCells
    34. Chahoud J, Zhang M, Shah A, Lin SH, Pisters LL, Tu SM. Managing seminomatous and nonseminomatous germ cell tumors. Curr Opin Oncol. 2018 05; 30(3):181-188. PMID: 29538040.
      Citations: 2     Fields:    Translation:Humans
    35. Reichard CA, Gregg JR, Achim MF, Aparicio AM, Pettaway CA, Pisters LL, Ward JF, Davis JW, Chapin BF. Radical Prostatectomy in Metastatic Castration-resistant Prostate Cancer: Feasibility, Safety, and Quality of Life Outcomes. Eur Urol. 2018 08; 74(2):140-143. PMID: 29656854.
      Citations: 5     Fields:    Translation:Humans
    36. Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen Q, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int. 2018 04; 121(4):540-548. PMID: 28941030.
      Citations: 8     Fields:    Translation:Humans
    37. Cox M, Basen-Engquist K, Carmack CL, Blalock J, Li Y, Murray J, Pisters L, Rodriguez-Bigas M, Song J, Cox-Martin E, Demark-Wahnefried W. Comparison of Internet and Telephone Interventions for Weight Loss Among Cancer Survivors: Randomized Controlled Trial and Feasibility Study. JMIR Cancer. 2017 Sep 27; 3(2):e16. PMID: 28954716; PMCID: PMC5637068.
      Citations: 11     
    38. Basourakos SP, Davis JW, Chapin BF, Ward JF, Pettaway CA, Pisters LL, Navai N, Achim MF, Wang X, Chen HC, Choi S, Kuban D, Troncoso P, Hanash S, Thompson TC, Kim J. Baseline and longitudinal plasma caveolin-1 level as a biomarker in active surveillance for early-stage prostate cancer. BJU Int. 2018 01; 121(1):69-76. PMID: 28710901; PMCID: PMC6126916.
      Citations: 6     Fields:    Translation:Humans
    39. Metcalfe MJ, Troncoso P, Guo CC, Chen HC, Bozkurt Y, Ward JF, Pisters LL. Salvage prostatectomy for post-radiation adenocarcinoma with treatment effect: Pathological and oncological outcomes. Can Urol Assoc J. 2017 Jul; 11(7):E277-E284. PMID: 28761588; PMCID: PMC5519386.
      Citations: 2     
    40. Malakorn S, Sammour T, Pisters LL, Chang GJ. Robotic Total Pelvic Exenteration. Dis Colon Rectum. 2017 May; 60(5):555. PMID: 28383456.
      Citations:    Fields:    Translation:Humans
    41. Tzortzis V, Samarinas M, Zachos I, Oeconomou A, Pisters LL, Bargiota A. Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications. Hormones (Athens). 2017 Apr; 16(2):115-123. PMID: 28742500.
      Citations: 11     Fields:    Translation:Humans
    42. Mustafa M, Davis JW, Gorgel SN, Pisters L. Robotic or Open Radical Prostatectomy in Men with Previous Transurethral Resection of Prostate. Urol J. 2017 Jan 18; 14(1):2955-2960. PMID: 28116739.
      Citations: 3     Fields:    Translation:Humans
    43. Bilen MA, Hess KR, Campbell MT, Wang J, Broaddus RR, Karam JA, Ward JF, Wood CG, Choi SL, Rao P, Zhang M, Naing A, General R, Cauley DH, Lin SH, Logothetis CJ, Pisters LL, Tu SM. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget. 2016 Dec 27; 7(52):86280-86289. PMID: 27861143; PMCID: PMC5349913.
      Citations: 14     Fields:    Translation:Humans
    44. Williams SB, Willis DL, Slack RS, Dickstein RJ, Parikh S, Chiong E, Siefker-Radtke AO, Guo CC, Czerniak BA, McConkey DJ, Shah JB, Pisters LL, Grossman HB, Dinney CP, Kamat AM, Fern?ndez MI. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer. BJU Int. 2017 05; 119(5):684-691. PMID: 27753185.
      Citations: 10     Fields:    Translation:Humans
    45. Pham MN, Apolo AB, De Santis M, Galsky MD, Leibovich BC, Pisters LL, Siefker-Radtke AO, Sonpavde G, Steinberg GD, Sternberg CN, Tagawa ST, Weizer AZ, Woods ME, Milowsky MI. Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer. World J Urol. 2017 Mar; 35(3):367-378. PMID: 27342991; PMCID: PMC6777567.
      Citations: 2     Fields:    Translation:Humans
    46. Kenney PA, Nawaf CB, Mustafa M, Wen S, Wszolek MF, Pettaway CA, Ward JF, Davis JW, Pisters LL. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Can J Urol. 2016 Jun; 23(3):8271-7. PMID: 27347619; PMCID: PMC5512888.
      Citations: 10     Fields:    Translation:Humans
    47. Milbury K, Lopez G, Spelman A, Wood C, Matin SF, Tannir NM, Jonasch E, Pisters L, Wei Q, Cohen L. Examination of moderators of expressive writing in patients with renal cell carcinoma: the role of depression and social support. Psychooncology. 2017 09; 26(9):1361-1368. PMID: 27145447; PMCID: PMC5094904.
      Citations: 11     Fields:    Translation:Humans
    48. Kim J, Davis JW, Klein EA, Magi-Galluzzi C, Lotan Y, Ward JF, Pisters LL, Basler JW, Pettaway CA, Stephenson A, Li Ning Tapia EM, Efstathiou E, Wang X, Do KA, Lee JJ, Gorlov IP, Vornik LA, Hoque AM, Prokhorova IN, Parnes HL, Lippman SM, Thompson IM, Brown PH, Logothetis CJ, Troncoso P. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine. 2016 May; 7:85-93. PMID: 27322462; PMCID: PMC4909608.
      Citations: 2     Fields:    Translation:Humans
    49. Tu SM, Bilen MA, Hess KR, Broaddus RR, Kopetz S, Wei C, Pagliaro LC, Karam JA, Ward JF, Wood CG, Rao P, Tu ZH, General R, Chen AH, Nieto YL, Yeung SC, Lin SH, Logothetis CJ, Pisters LL. Intratumoral heterogeneity: Role of differentiation in a potentially lethal phenotype of testicular cancer. Cancer. 2016 06 15; 122(12):1836-43. PMID: 27018785; PMCID: PMC5071733.
      Citations: 17     Fields:    Translation:HumansCells
    50. Mustafa M, Delacroix S, Ward JF, Pisters L. The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer. World J Surg Oncol. 2015 Dec 21; 13:340. PMID: 26691335; PMCID: PMC4687344.
      Citations: 1     Fields:    Translation:Humans
    51. Williams SB, Davis JW, Wang X, Achim MF, Zurita-Saavedra A, Matin SF, Pisters LL, Ward JF, Pettaway CA, Chapin BF. Neoadjuvant Systemic Therapy Before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity: Contemporary Results Using the Clavien System. Clin Genitourin Cancer. 2016 Apr; 14(2):130-8. PMID: 26558524.
      Citations: 4     Fields:    Translation:Humans
    52. Ho PL, Willis DL, Patil J, Xiao L, Williams SB, Melquist JJ, Tart K, Parikh S, Shah JB, Delacroix SE, Navai N, Siefker-Radtke A, Dinney CP, Pisters LL, Kamat AM. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy: The M.D. Anderson Cancer Center Experience. Urol Oncol. 2016 Feb; 34(2):59.e1-8. PMID: 26421586.
      Citations: 18     Fields:    Translation:Humans
    53. Dimitropoulos K, Karatzas A, Papandreou C, Daliani D, Zachos I, Pisters LL, Tzortzis V. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection: a focus beyond ejaculation disorders. Andrologia. 2016 May; 48(4):425-30. PMID: 26268684.
      Citations: 9     Fields:    Translation:Humans
    54. Davis JW, Ward JF, Pettaway CA, Wang X, Kuban D, Frank SJ, Lee AK, Pisters LL, Matin SF, Shah JB, Karam JA, Chapin BF, Papadopoulos JN, Achim M, Hoffman KE, Pugh TJ, Choi S, Troncoso P, Logothetis CJ, Kim J. Disease reclassification risk with stringent criteria and frequent monitoring in men with favourable-risk prostate cancer undergoing active surveillance. BJU Int. 2016 07; 118(1):68-76. PMID: 26059275; PMCID: PMC4808616.
      Citations: 17     Fields:    Translation:Humans
    55. Zurita AJ, Pisters LL, Wang X, Troncoso P, Dieringer P, Ward JF, Davis JW, Pettaway CA, Logothetis CJ, Pagliaro LC. Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer. Prostate Cancer Prostatic Dis. 2015 Sep; 18(3):276-80. PMID: 26171883; PMCID: PMC4821010.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    56. Thekdi SM, Milbury K, Spelman A, Wei Q, Wood C, Matin SF, Tannir N, Jonasch E, Pisters L, Cohen L. Posttraumatic stress and depressive symptoms in renal cell carcinoma: association with quality of life and utility of single-item distress screening. Psychooncology. 2015 Nov; 24(11):1477-84. PMID: 25690556; PMCID: PMC4539280.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    57. Merrill MM, Wood CG, Tannir NM, Slack RS, Babaian KN, Jonasch E, Pagliaro LC, Compton Z, Tamboli P, Sircar K, Pisters LL, Matin SF, Karam JA. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent. Urol Oncol. 2015 Apr; 33(4):166.e21-9. PMID: 25700975; PMCID: PMC4664068.
      Citations: 20     Fields:    Translation:Humans
    58. Mustafa M, Pettaway CA, Davis JW, Pisters L. Robotic or open radical prostatectomy after previous open surgery in the pelvic region. Korean J Urol. 2015 Feb; 56(2):131-7. PMID: 25685300; PMCID: PMC4325117.
      Citations: 2     Fields:    Translation:Humans
    59. Bilen MA, Reyes A, Bhowmick D, Maa A, Bast R, Pisters LL, Lin SH, Logothetis CJ, Tu SM. Variant prostate carcinoma and elevated serum CA-125. Can J Urol. 2014 Oct; 21(5):7442-8. PMID: 25347368; PMCID: PMC4400850.
      Citations: 2     Fields:    Translation:Humans
    60. Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM. Clinical outcomes of cT1 micropapillary bladder cancer. J Urol. 2015 Apr; 193(4):1129-34. PMID: 25254936; PMCID: PMC4687395.
      Citations: 26     Fields:    Translation:Humans
    61. Madsen LT, Kuban DA, Choi S, Davis JW, Kim J, Lee AK, Domain D, Levy L, Pisters LL, Pettaway CA, Ward JF, Logothetis C, Hoffman KE. Impact of a clinical trial initiative on clinical trial enrollment in a multidisciplinary prostate cancer clinic. J Natl Compr Canc Netw. 2014 Jul; 12(7):993-8. PMID: 24994920; PMCID: PMC4413899.
      Citations: 3     Fields:    Translation:Humans
    62. Prinsloo S, Wei Q, Scott SM, Tannir N, Jonasch E, Pisters L, Cohen L. Psychological states, serum markers and survival: associations and predictors of survival in patients with renal cell carcinoma. J Behav Med. 2015 Feb; 38(1):48-56. PMID: 24935017; PMCID: PMC4824635.
      Citations: 4     Fields:    Translation:Humans
    63. Bilen MA, Hariri H, Leon C, Guo CC, Kuban DA, Pisters LL, Tu SM. Positive FDG-PET/CT scans of a residual seminoma after chemotherapy and radiotherapy: case report and review of the literature. Clin Genitourin Cancer. 2014 Aug; 12(4):e147-50. PMID: 24674785; PMCID: PMC4104212.
      Citations: 1     Fields:    Translation:Humans
    64. Prensner JR, Chen W, Iyer MK, Cao Q, Ma T, Han S, Sahu A, Malik R, Wilder-Romans K, Navone N, Logothetis CJ, Araujo JC, Pisters LL, Tewari AK, Canman CE, Knudsen KE, Kitabayashi N, Rubin MA, Demichelis F, Lawrence TS, Chinnaiyan AM, Feng FY. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer. Cancer Res. 2014 Mar 15; 74(6):1651-60. PMID: 24473064; PMCID: PMC4009928.
      Citations: 136     Fields:    Translation:HumansAnimalsCells
    65. Milbury K, Spelman A, Wood C, Matin SF, Tannir N, Jonasch E, Pisters L, Wei Q, Cohen L. Randomized controlled trial of expressive writing for patients with renal cell carcinoma. J Clin Oncol. 2014 Mar 01; 32(7):663-70. PMID: 24470003; PMCID: PMC3927735.
      Citations: 18     Fields:    Translation:Humans
    66. Gilbert SM, Sanda MG, Dunn RL, Greenfield TK, Hembroff L, Klein E, Saigal CS, Pisters L, Michalski J, Sandler HM, Litwin MS, Wei JT. Satisfaction with information used to choose prostate cancer treatment. J Urol. 2014 May; 191(5):1265-71. PMID: 24333514; PMCID: PMC4283586.
      Citations: 7     Fields:    Translation:Humans
    67. Ward JF, Pisters LL. Considerations for patient selection for focal therapy. Ther Adv Urol. 2013 Dec; 5(6):330-7. PMID: 24294291; PMCID: PMC3825108.
      Citations: 1     
    68. Matin SF, Cormier JN, Ward JF, Pisters LL, Wood CG, Dinney CP, Royal RE, Huang X, Pettaway CA. Phase 1 prospective evaluation of the oncological adequacy of robotic assisted video-endoscopic inguinal lymphadenectomy in patients with penile carcinoma. BJU Int. 2013 Jun; 111(7):1068-74. PMID: 23551693; PMCID: PMC3651805.
      Citations: 22     Fields:    Translation:HumansCTClinical Trials
    69. Spiess PE, Levy DA, Mouraviev V, Pisters LL, Jones JS. Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model. BJU Int. 2013 Aug; 112(4):E256-61. PMID: 23469778.
      Citations: 7     Fields:    Translation:Humans
    70. Spiess PE, Levy DA, Pisters LL, Mouraviev V, Jones JS. Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: update from the COLD registry. World J Urol. 2013 Dec; 31(6):1321-5. PMID: 23179729.
      Citations: 10     Fields:    Translation:Humans
    71. Eastham JA, Carroll P, Pisters L, Nguyen PT, Touijer K. Salvage therapies after radiation therapy. Urol Oncol. 2012 Nov-Dec; 30(6):940-1. PMID: 23218071.
      Citations: 1     Fields:    Translation:Humans
    72. Cohen L, Cole SW, Sood AK, Prinsloo S, Kirschbaum C, Arevalo JM, Jennings NB, Scott S, Vence L, Wei Q, Kentor D, Radvanyi L, Tannir N, Jonasch E, Tamboli P, Pisters L. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLoS One. 2012; 7(8):e42324. PMID: 22870317; PMCID: PMC3409855.
      Citations: 60     Fields:    Translation:HumansCellsCTClinical Trials
    73. Efstathiou E, Karlou M, Wen S, Hoang A, Pettaway CA, Pisters LL, Maity S, Troncoso P, Logothetis CJ. Integrated Hedgehog signaling is induced following castration in human and murine prostate cancers. Prostate. 2013 Jan; 73(2):153-61. PMID: 22753310; PMCID: PMC3878994.
      Citations: 12     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    74. Leibovici D, Chiong E, Pisters LL, Guo CC, Ward JF, Andino L, Prokhorova IN, Troncoso P. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy. J Urol. 2012 Jul; 188(1):98-102. PMID: 22578724.
      Citations: 11     Fields:    Translation:Humans
    75. Parker PA, Swartz R, Fellman B, Urbauer D, Li Y, Pisters LL, Rosser CJ, Wood CG, Matin SF. Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery. J Urol. 2012 Mar; 187(3):822-6. PMID: 22245327; PMCID: PMC3866893.
      Citations: 14     Fields:    Translation:Humans
    76. Biegler K, Cohen L, Scott S, Hitzhusen K, Parker P, Gilts CD, Canada A, Pisters L. The role of religion and spirituality in psychological distress prior to surgery for urologic cancer. Integr Cancer Ther. 2012 Sep; 11(3):212-20. PMID: 21964511; PMCID: PMC3746331.
      Citations: 6     Fields:    Translation:Humans
    77. Alemozaffar M, Regan MM, Cooperberg MR, Wei JT, Michalski JM, Sandler HM, Hembroff L, Sadetsky N, Saigal CS, Litwin MS, Klein E, Kibel AS, Hamstra DA, Pisters LL, Kuban DA, Kaplan ID, Wood DP, Ciezki J, Dunn RL, Carroll PR, Sanda MG. Prediction of erectile function following treatment for prostate cancer. JAMA. 2011 Sep 21; 306(11):1205-14. PMID: 21934053; PMCID: PMC3831607.
      Citations: 86     Fields:    Translation:HumansPHPublic Health
    78. Tzelepi V, Efstathiou E, Wen S, Troncoso P, Karlou M, Pettaway CA, Pisters LL, Hoang A, Logothetis CJ, Pagliaro LC. Persistent, biologically meaningful prostate cancer after 1 year of androgen ablation and docetaxel treatment. J Clin Oncol. 2011 Jun 20; 29(18):2574-81. PMID: 21606419; PMCID: PMC3138635.
      Citations: 26     Fields:    Translation:HumansCellsCTClinical Trials
    79. Cohen L, Parker PA, Vence L, Savary C, Kentor D, Pettaway C, Babaian R, Pisters L, Miles B, Wei Q, Wiltz L, Patel T, Radvanyi L. Presurgical stress management improves postoperative immune function in men with prostate cancer undergoing radical prostatectomy. Psychosom Med. 2011 Apr; 73(3):218-25. PMID: 21257977.
      Citations: 17     Fields:    Translation:HumansCells
    80. Wiegand LR, Hernandez M, Pisters LL, Spiess PE. Surgical management of lymph-node-positive prostate cancer: improves symptomatic control. BJU Int. 2011 Apr; 107(8):1238-42. PMID: 20880197.
      Citations: 12     Fields:    Translation:Humans
    81. Som A, Zhu R, Guo CC, Efstathiou E, Xiao L, Pisters LL, Matin A, Tu SM. Recurrent seminomas: clinical features and biologic implications. Urol Oncol. 2012 Jul-Aug; 30(4):494-501. PMID: 20822932; PMCID: PMC3856193.
      Citations: 4     Fields:    Translation:Humans
    82. Sexton WJ, Spiess PE, Pisters LL, Carpenter S, Madsen LT, Zagone R, Wang X, Troncoso P. Are there differences in zonal distribution and tumor volume of prostate cancer in patients with a positive family history? Int Braz J Urol. 2010 Sep-Oct; 36(5):571-82. PMID: 21044374.
      Citations:    Fields:    Translation:Humans
    83. Okorie CO, Pisters LL. Effect of modified suprapubic prostatectomy for benign prostatic hyperplasia on postoperative hemoglobin levels. Can J Urol. 2010 Aug; 17(4):5255-8. PMID: 20735903.
      Citations: 1     Fields:    Translation:Humans
    84. Childs MA, Wood CG, Spiess PE, Debiane LG, Hernandez M, Matin SF, Millikan RE, Siefker-Radtkie A, Scott SM, Pisters LL. Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy. Can J Urol. 2010 Jun; 17(3):5184-9. PMID: 20566011.
      Citations: 4     Fields:    Translation:Humans
    85. Pisters LL. Cryotherapy for prostate cancer: ready for prime time? Curr Opin Urol. 2010 May; 20(3):218-22. PMID: 20224411.
      Citations: 1     Fields:    Translation:Humans
    86. Okorie CO, Pisters LL, Ndasi HT, Fekadu A. A simplified protocol for evaluating and monitoring urethral stricture patients minimizes cost without compromising patient outcome. Trop Doct. 2010 Jul; 40(3):134-7. PMID: 20413547.
      Citations: 3     Fields:    Translation:Humans
    87. Shinn EH, Swartz RJ, Thornton BB, Spiess PE, Pisters LL, Basen-Engquist KM. Testis cancer survivors' health behaviors: comparison with age-matched relative and demographically matched population controls. J Clin Oncol. 2010 May 01; 28(13):2274-9. PMID: 20368572; PMCID: PMC2860440.
      Citations: 11     Fields:    Translation:HumansAnimals
    88. Okorie CO, Pisters LL. Monti reconstruction in patients with complex vesicovaginal fistula. Can J Urol. 2010 Apr; 17(2):5124-6. PMID: 20398454.
      Citations:    Fields:    Translation:Humans
    89. Levy DA, Pisters LL, Jones JS. Prognostic value of initial prostate-specific antigen levels after salvage cryoablation for prostate cancer. BJU Int. 2010 Oct; 106(7):986-90. PMID: 20230388.
      Citations: 2     Fields:    Translation:Humans
    90. Punar M, Tamboli P, Tu SM, Pisters L, Moran C, Czerniak BA, Guo CC, Contreras AL. Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol. 2010 Jun; 41(6):832-7. PMID: 20153508; PMCID: PMC4163004.
      Citations: 7     Fields:    Translation:Humans
    91. Zafirakis H, De EJ, Pisters LL, Pettaway C, Westney OL. Long-term outcomes and patient satisfaction of continent catheterizable limb and augmentation cystoplasty simultaneous with salvage prostatectomy. Neurourol Urodyn. 2010; 29 Suppl 1:S51-6. PMID: 20419802.
      Citations:    Fields:    Translation:Humans
    92. Taylor JM, Spiess PE, Kassouf W, Munsell MF, Kamat AM, Dinney CP, Grossman HB, Pisters LL. Management of urethral recurrence after orthotopic urinary diversion. BJU Int. 2010 Jul; 106(1):56-61. PMID: 20002676.
      Citations: 7     Fields:    Translation:Humans
    93. Spiess PE, Katz AE, Chin JL, Bahn D, Cohen JK, Shinohara K, Hernandez M, Bossier J, Kassouf W, Pisters LL. A pretreatment nomogram predicting biochemical failure after salvage cryotherapy for locally recurrent prostate cancer. BJU Int. 2010 Jul; 106(2):194-8. PMID: 19922545.
      Citations: 11     Fields:    Translation:Humans
    94. Okorie CO, Salia M, Liu P, Pisters LL. Modified suprapubic prostatectomy without irrigation is safe. Urology. 2010 Mar; 75(3):701-5. PMID: 19914705.
      Citations: 3     Fields:    Translation:Humans
    95. Davis JW, Kamat A, Munsell M, Pettaway C, Pisters L, Matin S. Initial experience of teaching robot-assisted radical prostatectomy to surgeons-in-training: can training be evaluated and standardized? BJU Int. 2010 Apr; 105(8):1148-54. PMID: 19874300.
      Citations: 12     Fields:    Translation:Humans
    96. Chiong E, Hegarty PK, Davis JW, Kamat AM, Pisters LL, Matin SF. Port-site hernias occurring after the use of bladeless radially expanding trocars. Urology. 2010 Mar; 75(3):574-80. PMID: 19854489.
      Citations: 22     Fields:    Translation:Humans
    97. Efstathiou E, Abrahams NA, Tibbs RF, Wang X, Pettaway CA, Pisters LL, Mathew PF, Do KA, Logothetis CJ, Troncoso P. Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification. Eur Urol. 2010 Jun; 57(6):1030-8. PMID: 19853370; PMCID: PMC2962710.
      Citations: 20     Fields:    Translation:Humans
    98. Raz O, Pisters LL, Spiess PE, Lindner A, Leibovici D. [Palliative surgery for locally advanced prostate cancer]. Harefuah. 2009 Aug; 148(8):535-8, 571. PMID: 19899258.
      Citations:    Fields:    Translation:Humans
    99. Guo CC, Punar M, Tu SM, Pisters L, Tamboli P, Czerniak B, Contreras AL. Testicular germ cell tumors with sarcomatous components: an analysis of 33 cases. Am J Surg Pathol. 2009 Aug; 33(8):1173-8. PMID: 19561445; PMCID: PMC3812063.
      Citations: 19     Fields:    Translation:Humans
    100. Levy DA, Pisters LL, Jones JS. Primary cryoablation nadir prostate specific antigen and biochemical failure. J Urol. 2009 Sep; 182(3):931-7. PMID: 19616226.
      Citations: 7     Fields:    Translation:Humans
    101. Tu SM, Lopez A, Leibovici D, Bilen MA, Evliyaoglu F, Aparicio A, Guo CC, Kuban DA, Johnson MM, Pisters LL. Ductal adenocarcinoma of the prostate: clinical features and implications after local therapy. Cancer. 2009 Jul 01; 115(13):2872-80. PMID: 19402048.
      Citations: 20     Fields:    Translation:Humans
    102. Pisters LL, Leibovici D, Blute M, Zincke H, Sebo TJ, Slezak JM, Izawa J, Ward JF, Scott SM, Madsen L, Spiess PE, Leibovich BC. Locally recurrent prostate cancer after initial radiation therapy: a comparison of salvage radical prostatectomy versus cryotherapy. J Urol. 2009 Aug; 182(2):517-25; discussion 525-7. PMID: 19524984.
      Citations: 26     Fields:    Translation:Humans
    103. Parker PA, Pettaway CA, Babaian RJ, Pisters LL, Miles B, Fortier A, Wei Q, Carr DD, Cohen L. The effects of a presurgical stress management intervention for men with prostate cancer undergoing radical prostatectomy. J Clin Oncol. 2009 Jul 01; 27(19):3169-76. PMID: 19349551; PMCID: PMC2716938.
      Citations: 18     Fields:    Translation:Humans
    104. Gorbatiy V, Spiess PE, Pisters LL. The growing teratoma syndrome: Current review of the literature. Indian J Urol. 2009 Apr; 25(2):186-9. PMID: 19672343; PMCID: PMC2710061.
      Citations: 19     
    105. Svatek RS, Spiess PE, Sundi D, Tu SM, Tannir NM, Brown GA, Kamat AM, Wood CG, Pisters LL. Long-term outcome for men with teratoma found at postchemotherapy retroperitoneal lymph node dissection. Cancer. 2009 Mar 15; 115(6):1310-7. PMID: 19156903.
      Citations: 3     Fields:    Translation:Humans
    106. Tsavachidou D, McDonnell TJ, Wen S, Wang X, Vakar-Lopez F, Pisters LL, Pettaway CA, Wood CG, Do KA, Thall PF, Stephens C, Efstathiou E, Taylor R, Menter DG, Troncoso P, Lippman SM, Logothetis CJ, Kim J. Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 04; 101(5):306-20. PMID: 19244175; PMCID: PMC2734116.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    107. Ward JF, Nakanishi H, Pisters L, Babaian RJ, Troncoso P. Cancer ablation with regional templates applied to prostatectomy specimens from men who were eligible for focal therapy. BJU Int. 2009 Aug; 104(4):490-7. PMID: 19220260.
      Citations: 17     Fields:    Translation:Humans
    108. Forrest JB, Clemens JQ, Finamore P, Leveillee R, Lippert M, Pisters L, Touijer K, Whitmore K, American Urological Association. AUA Best Practice Statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery. J Urol. 2009 Mar; 181(3):1170-7. PMID: 19152926.
      Citations: 30     Fields:    Translation:Humans
    109. Guo CC, Pisters LL, Troncoso P. Prostate cancer invading the rectum: a clinicopathological study of 18 cases. Pathology. 2009; 41(6):539-43. PMID: 19900102.
      Citations: 6     Fields:    Translation:Humans
    110. Williams DH, Karpman E, Sander JC, Spiess PE, Pisters LL, Lipshultz LI. Pretreatment semen parameters in men with cancer. J Urol. 2009 Feb; 181(2):736-40. PMID: 19091343.
      Citations: 34     Fields:    Translation:Humans
    111. Mathew P, Pisters LL, Wood CG, Papadopoulos JN, Williams DL, Thall PF, Wen S, Horne E, Oborn CJ, Langley R, Fidler IJ, Pettaway CA. Neoadjuvant platelet derived growth factor receptor inhibitor therapy combined with docetaxel and androgen ablation for high risk localized prostate cancer. J Urol. 2009 Jan; 181(1):81-7; discussion 87. PMID: 19012911.
      Citations: 13     Fields:    Translation:Humans
    112. Ward JF, Pagliaro LC, Pisters LL. Salvage therapy for radiorecurrent prostate cancer. Curr Probl Cancer. 2008 Nov-Dec; 32(6):242-71. PMID: 19064119.
      Citations: 9     Fields:    Translation:Humans
    113. Kassouf W, Agarwal PK, Grossman HB, Leibovici D, Munsell MF, Siefker-Radtke A, Pisters LL, Swanson DA, Dinney CP, Kamat AM. Outcome of patients with bladder cancer with pN+ disease after preoperative chemotherapy and radical cystectomy. Urology. 2009 Jan; 73(1):147-52. PMID: 18848348; PMCID: PMC2674246.
      Citations: 21     Fields:    Translation:Humans
    114. Babaian RJ, Donnelly B, Bahn D, Baust JG, Dineen M, Ellis D, Katz A, Pisters L, Rukstalis D, Shinohara K, Thrasher JB. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008 Nov; 180(5):1993-2004. PMID: 18817934.
      Citations: 69     Fields:    Translation:Humans
    115. Davis JW, Chang DW, Chevray P, Wang R, Shen Y, Wen S, Pettaway CA, Pisters LL, Swanson DA, Madsen LT, Huber N, Troncoso P, Babaian RJ, Wood CG. Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancer. Eur Urol. 2009 May; 55(5):1135-43. PMID: 18783876; PMCID: PMC10651170.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    116. Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS. Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008 Aug; 180(2):559-63; discussion 563-4. PMID: 18554664.
      Citations: 37     Fields:    Translation:Humans
    117. Jones JS, Rewcastle JC, Donnelly BJ, Lugnani FM, Pisters LL, Katz AE. Whole gland primary prostate cryoablation: initial results from the cryo on-line data registry. J Urol. 2008 Aug; 180(2):554-8. PMID: 18550117.
      Citations: 29     Fields:    Translation:Humans
    118. Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L, Lin X, Greenfield TK, Litwin MS, Saigal CS, Mahadevan A, Klein E, Kibel A, Pisters LL, Kuban D, Kaplan I, Wood D, Ciezki J, Shah N, Wei JT. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008 Mar 20; 358(12):1250-61. PMID: 18354103.
      Citations: 685     Fields:    Translation:Humans
    119. Pisters LL. Treatment failure after primary and salvage therapy for prostate cancer. Cancer. 2008 Jan 15; 112(2):225-7. PMID: 18050293.
      Citations: 1     Fields:    Translation:Humans
    120. Spiess PE, Pisters LL, Liu P, Pettaway CA, Kamat AM, Gomez JA, Tannir NM. Malignant transformation of testicular teratoma: a chemoresistant phenotype. Urol Oncol. 2008 Nov-Dec; 26(6):595-9. PMID: 18367105; PMCID: PMC4121060.
      Citations: 10     Fields:    Translation:Humans
    121. Kassouf W, Agarwal PK, Herr HW, Munsell MF, Spiess PE, Brown GA, Pisters L, Grossman HB, Dinney CP, Kamat AM. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC. J Clin Oncol. 2008 Jan 01; 26(1):121-6. PMID: 18165646.
      Citations: 43     Fields:    Translation:Humans
    122. Sabichi AL, Lerner SP, Atkinson EN, Grossman HB, Caraway NP, Dinney CP, Penson DF, Matin S, Kamat A, Pisters LL, Lin DW, Katz RL, Brenner DE, Hemstreet GP, Wargo M, Bleyer A, Sanders WH, Clifford JL, Parnes HL, Lippman SM. Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancer. Clin Cancer Res. 2008 Jan 01; 14(1):224-9. PMID: 18172274.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    123. Spiess PE, Tannir NM, Tu SM, Brown GA, Liu P, Kamat AM, Wood CG, Evans JG, Pisters LL. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression? Cancer. 2007 Dec 15; 110(12):2700-8. PMID: 17948916.
      Citations: 4     Fields:    Translation:Humans
    124. Spiess PE, Tannir NM, Brown GA, Liu P, Tu SM, Evans JG, Pisters LL. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection. Urology. 2007 Dec; 70(6):1173-8. PMID: 18158041.
      Citations:    Fields:    Translation:Humans
    125. Shetty AM, Stafford RJ, Elliott AM, Kassouf W, Brown GA, Stephens LC, Tinkey PT, Bidaut L, Pisters LL, Hazle JD. Magnetic resonance imaging assessment of a convective therapy delivery paradigm in a canine prostate model. J Magn Reson Imaging. 2007 Dec; 26(6):1672-7. PMID: 17968888.
      Citations:    Fields:    Translation:Animals
    126. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL. Salvage surgery for locally recurrent prostate cancer after radiation therapy: tricks of the trade. Urol Oncol. 2008 Jan-Feb; 26(1):9-16. PMID: 18190824.
      Citations: 7     Fields:    Translation:Humans
    127. Spiess PE, Busby JE, Jordan JJ, Steinberg JR, Bassett RL, Davuluri R, Burt K, Troncoso P, Lee AK, Taylor SH, Pisters LL. Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer? Urol Oncol. 2008 Jan-Feb; 26(1):25-30. PMID: 18190826.
      Citations: 1     Fields:    Translation:Humans
    128. Kassouf W, Brown GA, Shetty A, Hazle JD, Stafford RJ, Rosser CJ, Stephens C, Tinkey PT, Pisters LL. An in vivo orthotopic canine model to evaluate distribution of intraprostatic injectate: implications for gene therapy and drug delivery for prostate cancer. Urology. 2007 Oct; 70(4):822-5. PMID: 17991580.
      Citations: 2     Fields:    Translation:Animals
    129. Leibovici D, Kassouf W, Pisters LL, Pettaway CA, Wu X, Dinney CP, Grossman HB. Organ preservation for muscle-invasive bladder cancer by transurethral resection. Urology. 2007 Sep; 70(3):473-6. PMID: 17905099.
      Citations: 10     Fields:    Translation:Humans
    130. Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, Detry MA, Robinson TL, Pisters LL. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer. 2007 Jul 01; 110(1):62-7. PMID: 17542024.
      Citations: 59     Fields:    Translation:Humans
    131. Black PC, Basen-Engquist K, Wang X, Swartz RJ, Eddings T, Matin SF, Swanson D, Wood CG, Pisters LL, Babaian RJ, Troncoso P, Pettaway CA. A randomized prospective trial evaluating testosterone, haemoglobin kinetics and quality of life, during and after 12 months of androgen deprivation after prostatectomy: results from the Postoperative Adjuvant Androgen Deprivation trial. BJU Int. 2007 Jul; 100(1):63-9. PMID: 17552954.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    132. De E, Pisters LL, Pettaway CA, Scott S, Westney OL. Salvage prostatectomy with bladder neck closure, continent catheterizable stoma and bladder augmentation: feasibility and patient reported continence outcomes at 32 months. J Urol. 2007 Jun; 177(6):2200-4; discussion 2204. PMID: 17509319.
      Citations: 1     Fields:    Translation:Humans
    133. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol. 2007 Jun; 177(6):2151-6; discussion 2156. PMID: 17509305.
      Citations: 32     Fields:    Translation:Humans
    134. Spiess PE, Kassouf W, Brown GA, Kamat AM, Liu P, Gomez JA, Tu SM, Tannir NM, Pisters LL. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol. 2007 Apr; 177(4):1330-4; discussion 1334. PMID: 17382725.
      Citations: 26     Fields:    Translation:Humans
    135. Shinn EH, Basen-Engquist K, Thornton B, Spiess PE, Pisters L. Health behaviors and depressive symptoms in testicular cancer survivors. Urology. 2007 Apr; 69(4):748-53. PMID: 17445663; PMCID: PMC2674069.
      Citations: 18     Fields:    Translation:Humans
    136. Efstathiou E, Troncoso P, Wen S, Do KA, Pettaway CA, Pisters LL, McDonnell TJ, Logothetis CJ. Initial modulation of the tumor microenvironment accounts for thalidomide activity in prostate cancer. Clin Cancer Res. 2007 Feb 15; 13(4):1224-31. PMID: 17317833.
      Citations: 24     Fields:    Translation:HumansCellsCTClinical Trials
    137. Leibovici D, Spiess PE, Agarwal PK, Tu SM, Pettaway CA, Hitzhusen K, Millikan RE, Pisters LL. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level. Cancer. 2007 Jan 15; 109(2):198-204. PMID: 17171704.
      Citations: 30     Fields:    Translation:Humans
    138. Spiess PE, Brown GA, Liu P, Tu SM, Tannir NM, Evans JG, Kamat AM, Kassouf W, Pisters LL. Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node dissection. J Urol. 2007 Jan; 177(1):131-8. PMID: 17162023.
      Citations:    Fields:    Translation:HumansPHPublic Health
    139. Pendleton J, Pisters LL, Nakamura K, Anai S, Rosser CJ. Neoadjuvant therapy before radical prostatectomy: where have we been? Where are we going? Urol Oncol. 2007 Jan-Feb; 25(1):11-8. PMID: 17208133.
      Citations: 8     Fields:    Translation:Humans
    140. Brown GA, Busby JE, Wood CG, Pisters LL, Dinney CP, Swanson DA, Grossman HB, Pettaway CA, Munsell MF, Kamat AM, Matin SF. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? BJU Int. 2006 Dec; 98(6):1176-80. PMID: 17125474.
      Citations: 30     Fields:    Translation:Humans
    141. Spiess PE, Lee AK, Busby JE, Jordan JJ, Hernandez M, Burt K, Troncoso P, Merriman KW, Pisters LL. Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome? BJU Int. 2007 Feb; 99(2):321-5. PMID: 17155975.
      Citations: 6     Fields:    Translation:Humans
    142. Spiess PE, Brown GA, Liu P, Tannir NM, Tu SM, Evans JG, Czerniak B, Kamat AM, Pisters LL. Predictors of outcome in patients undergoing postchemotherapy retroperitoneal lymph node dissection for testicular cancer. Cancer. 2006 Oct 01; 107(7):1483-90. PMID: 16944541.
      Citations: 7     Fields:    Translation:Humans
    143. Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters? Cancer. 2006 Oct 01; 107(7):1503-10. PMID: 16944534.
      Citations: 7     Fields:    Translation:Humans
    144. Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, Dinney CP, Pisters LL. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. J Urol. 2006 Oct; 176(4 Pt 1):1463-7. PMID: 16952661.
      Citations: 27     Fields:    Translation:Humans
    145. Izawa JI, Busby JE, Morganstern N, Vakar-Lopez F, Scott SM, Pisters LL. Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsy. BJU Int. 2006 Sep; 98(3):554-8. PMID: 16925753.
      Citations: 2     Fields:    Translation:Humans
    146. Westney OL, Scott S, Wood C, Eddings T, Johnson MM, Taylor JM, McGuire E, Pisters LL. Suburethral sling at the time of radical prostatectomy in patients at high risk of postoperative incontinence. BJU Int. 2006 Aug; 98(2):308-13. PMID: 16879670.
      Citations: 1     Fields:    Translation:Humans
    147. Strom SS, Kamat AM, Gruschkus SK, Gu Y, Wen S, Cheung MR, Pisters LL, Lee AK, Rosser CJ, Kuban DA. Influence of obesity on biochemical and clinical failure after external-beam radiotherapy for localized prostate cancer. Cancer. 2006 Aug 01; 107(3):631-9. PMID: 16802288.
      Citations: 23     Fields:    Translation:Humans
    148. Spiess PE, Lee AK, Leibovici D, Wang X, Do KA, Pisters LL. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer. 2006 Jul 15; 107(2):275-80. PMID: 16770783.
      Citations: 8     Fields:    Translation:Humans
    149. Rosser CJ, Kamat AM, Pendleton J, Robinson TL, Pisters LL, Swanson DA, Babaian RJ. Impact of fellowship training on pathologic outcomes and complication rates of radical prostatectomy. Cancer. 2006 Jul 01; 107(1):54-9. PMID: 16708356.
      Citations: 12     Fields:    Translation:Humans
    150. Spiess PE, Leibovici D, Pisters LL. Surgery for locally advanced disease. Curr Urol Rep. 2006 May; 7(3):209-16. PMID: 16630524.
      Citations:    Fields:    Translation:Humans
    151. Rosser CJ, Kamat AM, Wang X, Do KA, Naya Y, Hoover DC, Troncoso P, Sanches-Ortiz RF, Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with radical prostatectomy. Urology. 2006 Apr; 67(4):769-73. PMID: 16584762.
      Citations: 2     Fields:    Translation:Humans
    152. Sabichi AL, Lee JJ, Taylor RJ, Thompson IM, Miles BJ, Tangen CM, Minasian LM, Pisters LL, Caton JR, Basler JW, Lerner SP, Menter DG, Marshall JR, Crawford ED, Lippman SM. Selenium accumulation in prostate tissue during a randomized, controlled short-term trial of l-selenomethionine: a Southwest Oncology Group Study. Clin Cancer Res. 2006 Apr 01; 12(7 Pt 1):2178-84. PMID: 16609032.
      Citations: 15     Fields:    Translation:Humans
    153. Kamat AM, Gee JR, Dinney CP, Grossman HB, Swanson DA, Millikan RE, Detry MA, Robinson TL, Pisters LL. The case for early cystectomy in the treatment of nonmuscle invasive micropapillary bladder carcinoma. J Urol. 2006 Mar; 175(3 Pt 1):881-5. PMID: 16469571.
      Citations: 45     Fields:    Translation:Humans
    154. Taylor SH, Merriman KW, Spiess PE, Pisters L. Inadequacies of the current American Joint Committee on cancer staging system for prostate cancer. Cancer. 2006 Feb 01; 106(3):559-65. PMID: 16369982.
      Citations: 6     Fields:    Translation:Humans
    155. Leibovici D, Kamat AM, Pettaway CA, Pagliaro L, Rosser CJ, Logothetis C, Pisters LL. Cystoprostatectomy for effective palliation of symptomatic bladder invasion by prostate cancer. J Urol. 2005 Dec; 174(6):2186-90. PMID: 16280761.
      Citations: 13     Fields:    Translation:Humans
    156. Cheung R, Kamat AM, de Crevoisier R, Allen PK, Lee AK, Tucker SL, Pisters L, Babaian RJ, Kuban D. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy. Int J Radiat Oncol Biol Phys. 2005 Sep 01; 63(1):134-40. PMID: 16111581.
      Citations: 12     Fields:    Translation:Humans
    157. Rosser CJ, Kamat AM, Wang X, Do KA, Sanchez-Ortiz RF, Kuban DA, Lee AK, Cheung R, Chichakli R, Pisters LL. Is patient age a factor in the occurrence of prostate-specific antigen bounce phenomenon after external beam radiotherapy for prostate cancer? Urology. 2005 Aug; 66(2):327-31. PMID: 16040084.
      Citations: 7     Fields:    Translation:Humans
    158. Kim J, Sun P, Lam YW, Troncoso P, Sabichi AL, Babaian RJ, Pisters LL, Pettaway CA, Wood CG, Lippman SM, McDonnell TJ, Lieberman R, Logothetis C, Ho SM. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer. Cancer Epidemiol Biomarkers Prev. 2005 Jul; 14(7):1697-702. PMID: 16030104.
      Citations: 7     Fields:    Translation:HumansCTClinical Trials
    159. Leibovici D, Lee AK, Cheung RM, Spiess PE, Kuban DA, Rosser CJ, Shen Y, Yang Y, Chichakli R, Pisters LL. Symptomatic local recurrence of prostate carcinoma after radiation therapy. Cancer. 2005 May 15; 103(10):2060-6. PMID: 15822114.
      Citations: 1     Fields:    Translation:Humans
    160. Ahrar K, Matin S, Wood CG, Wallace MJ, Gupta S, Madoff DC, Rao S, Tannir NM, Jonasch E, Pisters LL, Rozner MA, Kennamer DL, Hicks ME. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol. 2005 May; 16(5):679-88. PMID: 15872323.
      Citations: 20     Fields:    Translation:Humans
    161. Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15; 61(4):993-1002. PMID: 15752878.
      Citations: 16     Fields:    Translation:Humans
    162. Kamat AM, Carpenter SM, Czerniak BA, Pisters LL. Metastatic penile cancer in a young Caucasian male: impact of delayed diagnosis. Urol Oncol. 2005 Mar-Apr; 23(2):130-1. PMID: 15869998.
      Citations:    Fields:    Translation:Humans
    163. Leibovici D, Pagliaro L, Rosser CJ, Pisters LL. Salvage surgery for bulky local recurrence of prostate cancer following radical prostatectomy. J Urol. 2005 Mar; 173(3):781-3. PMID: 15711269.
      Citations: 7     Fields:    Translation:Humans
    164. Leibovici D, Kamat AM, Do KA, Pettaway CA, Ng CS, Evans RB, Rodriguez-Bigas M, Skibber J, Wang X, Pisters LL. Transrectal ultrasound versus magnetic resonance imaging for detection of rectal wall invasion by prostate cancer. Prostate. 2005 Jan 01; 62(1):101-4. PMID: 15389800.
      Citations: 6     Fields:    Translation:Humans
    165. Cheung R, Tucker SL, Lee AL, Dong L, Kamat A, Pisters L, Kuban DA. Assessing the impact of an alternative biochemical failure definition on radiation dose response for high-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jan 01; 61(1):14-9. PMID: 15629589.
      Citations: 5     Fields:    Translation:Humans
    166. Siefker-Radtke AO, Dinney CP, Abrahams NA, Moran C, Shen Y, Pisters LL, Grossman HB, Swanson DA, Millikan RE. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M. D. Anderson cancer experience. J Urol. 2004 Aug; 172(2):481-4. PMID: 15247709.
      Citations: 65     Fields:    Translation:Humans
    167. Rosser CJ, Kuban DA, Lee SJ, Levy LB, Pettaway C, Kamat AM, Chichakli R, Lee A, Cheung RM, Sanchez-Ortiz R, Pisters LL. Racial influence on biochemical disease-free survival in men treated with external-beam radiotherapy for localized prostate cancer. J Natl Med Assoc. 2004 Jul; 96(7):939-44. PMID: 15253325; PMCID: PMC2568437.
      Citations: 7     Fields:    Translation:Humans
    168. Kamat AM, Rosser CJ, Levy LB, Chichakli R, Lee AK, Cheung MR, Pisters LL. Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure. Urology. 2004 Jun; 63(6):1132-7. PMID: 15183966.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    169. Pisters LL, Pettaway CA, Troncoso P, McDonnell TJ, Stephens LC, Wood CG, Do KA, Brisbay SM, Wang X, Hossan EA, Evans RB, Soto C, Jacobson MG, Parker K, Merritt JA, Steiner MS, Logothetis CJ. Evidence that transfer of functional p53 protein results in increased apoptosis in prostate cancer. Clin Cancer Res. 2004 Apr 15; 10(8):2587-93. PMID: 15102659.
      Citations: 14     Fields:    Translation:HumansCells
    170. Rosser CJ, Tanaka M, Pisters LL, Tanaka N, Levy LB, Hoover DC, Grossman HB, McDonnell TJ, Kuban DA, Meyn RE. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expressing prostate cancer cells to radiation. Cancer Gene Ther. 2004 Apr; 11(4):273-9. PMID: 14765130.
      Citations: 16     Fields:    Translation:HumansCells
    171. Siefker-Radtke AO, Walsh GL, Pisters LL, Shen Y, Swanson DA, Logothetis CJ, Millikan RE. Is there a role for surgery in the management of metastatic urothelial cancer? The M. D. Anderson experience. J Urol. 2004 Jan; 171(1):145-8. PMID: 14665863.
      Citations: 47     Fields:    Translation:Humans
    172. Kamat AM, Shock RP, Naya Y, Rosser CJ, Slaton JW, Pisters LL. Prognostic value of body mass index in patients undergoing nephrectomy for localized renal tumors. Urology. 2004 Jan; 63(1):46-50. PMID: 14751346.
      Citations: 31     Fields:    Translation:Humans
    173. Lawrence G, Crawford J. Systemic benefit of local radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Dec 01; 57(5):1510-1; author reply 1511. PMID: 14630294.
      Citations:    Fields:    Translation:Humans
    174. Rosser CJ, Kuban DA, Levy LB, Pettaway CA, Chichakli R, Kamat AM, Sanchez-Ortiz RF, Pisters LL. Clinical features and treatment outcome of Hispanic men with prostate cancer following external beam radiotherapy. J Urol. 2003 Nov; 170(5):1856-9. PMID: 14532792.
      Citations: 2     Fields:    Translation:Humans
    175. Kamat AM, Huang SF, Bermejo CE, Rosser CJ, Pettaway CA, Pisters PW, Guitreau D, Pisters LL. Total pelvic exenteration: effective palliation of perineal pain in patients with locally recurrent prostate cancer. J Urol. 2003 Nov; 170(5):1868-71. PMID: 14532795.
      Citations: 13     Fields:    Translation:Humans
    176. Sweeney P, Wood CG, Pisters LL, Slaton JW, Vaporciyan A, Munsell M, Carpenter S, Putnam J, Swisher SG, Walsh G, Swanson D, Dinney CP. Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urol Oncol. 2003 Sep-Oct; 21(5):327-33. PMID: 14670538.
      Citations: 21     Fields:    Translation:Humans
    177. Taylor N, Kelly JF, Kuban DA, Babaian RJ, Pisters LL, Pollack A. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 2003 Jul 01; 56(3):755-63. PMID: 12788182.
      Citations: 21     Fields:    Translation:Humans
    178. Izawa JI, Morganstern N, Chan DM, Levy LB, Scott SM, Pisters LL. Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Jun 01; 56(2):468-72. PMID: 12738322.
      Citations: 2     Fields:    Translation:Humans
    179. Sweeney P, Millikan R, Donat M, Wood CG, Radtke AS, Pettaway CA, Grossman HB, Dinney CP, Swanson DA, Pisters LL. Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J Urol. 2003 Jun; 169(6):2113-7. PMID: 12771730.
      Citations: 39     Fields:    Translation:HumansCTClinical Trials
    180. Bermejo CE, Pisters LL. Cryotherapy for prostate cancer. Expert Rev Anticancer Ther. 2003 Jun; 3(3):393-401. PMID: 12820781.
      Citations: 2     Fields:    Translation:HumansAnimals
    181. Rosser CJ, Levy LB, Kuban DA, Chichakli R, Pollack A, Lee A, Pisters LL. Hazard rates of disease progression after external beam radiotherapy for clinically localized carcinoma of the prostate. J Urol. 2003 Jun; 169(6):2160-5. PMID: 12771739.
      Citations: 2     Fields:    Translation:Humans
    182. Rosser CJ, Reyes AO, Vakar-Lopez F, Levy LB, Kuban DA, Hoover DC, Lee AK, Pisters LL. Bcl-2 is significantly overexpressed in localized radio-recurrent prostate carcinoma, compared with localized radio-naive prostate carcinoma. Int J Radiat Oncol Biol Phys. 2003 May 01; 56(1):1-6. PMID: 12694817.
      Citations: 21     Fields:    Translation:Humans
    183. Siefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE, Pisters LL. Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 2003 Apr; 169(4):1295-8. PMID: 12629346.
      Citations: 89     Fields:    Translation:Humans
    184. Sexton WJ, Wood CG, Kim R, Pisters LL. Repeat retroperitoneal lymph node dissection for metastatic testis cancer. J Urol. 2003 Apr; 169(4):1353-6. PMID: 12629359.
      Citations: 9     Fields:    Translation:Humans
    185. Pisters LL. Salvage radical prostatectomy: refinement of an effective procedure. Semin Radiat Oncol. 2003 Apr; 13(2):166-74. PMID: 12728446.
      Citations: 5     Fields:    Translation:Humans
    186. Rosser CJ, Kuban DA, Levy LB, Chichakli R, Pollack A, Lee AK, Pisters LL. Prostate specific antigen bounce phenomenon after external beam radiation for clinically localized prostate cancer. J Urol. 2002 Nov; 168(5):2001-5. PMID: 12394695.
      Citations: 17     Fields:    Translation:Humans
    187. Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation. J Urol. 2002 Aug; 168(2):536-41. PMID: 12131304.
      Citations: 10     Fields:    Translation:Humans
    188. Sweeney P, El-Naggar AK, Lin SH, Pisters LL. Biological significance of c-met over expression in papillary renal cell carcinoma. J Urol. 2002 Jul; 168(1):51-5. PMID: 12050491.
      Citations: 19     Fields:    Translation:Humans
    189. Izawa JI, Madsen LT, Scott SM, Tran JP, McGuire EJ, Von Eschenbach AC, Pisters LL. Salvage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol. 2002 Jun 01; 20(11):2664-71. PMID: 12039928.
      Citations: 26     Fields:    Translation:Humans
    190. Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features. Cancer. 2002 May 15; 94(10):2610-7. PMID: 12173328.
      Citations: 40     Fields:    Translation:Humans
    191. Davis JW, Pisters LL, Doviak MJ, Donat SM. Early nasogastric tube removal combined with metoclopramide after postchemotherapy retroperitoneal lymph node dissection for metastatic testicular nonseminomatous germ cell tumor. Urology. 2002 Apr; 59(4):579-83. PMID: 11927318.
      Citations: 2     Fields:    Translation:Humans
    192. Fizazi K, Martinez LA, Sikes CR, Johnston DA, Stephens LC, McDonnell TJ, Logothetis CJ, Trapman J, Pisters LL, Troncoso P, Navone NM, Ordo?ez NG. The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer. Clin Cancer Res. 2002 Mar; 8(3):775-81. PMID: 11895908.
      Citations: 19     Fields:    Translation:HumansAnimals
    193. Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, Pisters LL. Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol. 2002 Jan; 167(1):65-70. PMID: 11743277.
      Citations: 71     Fields:    Translation:Humans
    194. Kent D, Gee JR, Amato RJ, Pisters LL. Successful management of metastatic urethral cancer with organ preservation. J Urol. 2001 Dec; 166(6):2308. PMID: 11696764.
      Citations: 1     Fields:    Translation:Humans
    195. Giesler EJ, Gee JR, Reece GP, Pettaway CA, Pollock RE, Pisters LL. Cutaneous metastases of penile squamous cell carcinoma following en bloc resection of inguinal recurrence with immediate pedicle flap reconstruction. J Urol. 2001 Oct; 166(4):1384-5. PMID: 11547082.
      Citations: 1     Fields:    Translation:Humans
    196. Sexton WJ, Lance RE, Reyes AO, Pisters PW, Tu SM, Pisters LL. Adult prostate sarcoma: the M. D. Anderson Cancer Center Experience. J Urol. 2001 Aug; 166(2):521-5. PMID: 11458058.
      Citations: 44     Fields:    Translation:Humans
    197. Lance RS, Dinney CP, Swanson D, Babaian RJ, Pisters LL, Palmer LJ, Grossman HB. Radical cystectomy for invasive bladder cancer in the octogenarian. Oncol Rep. 2001 Jul-Aug; 8(4):723-6. PMID: 11410772.
      Citations: 7     Fields:    Translation:Humans
    198. Pisters LL, Wang XH, Chung LW, Hsieh JT. Differential expression of c-erb B2/neu, epidermal growth factor receptor, cytokeratin 8, and the prostatic steroid-binding protein gene in rat ventral prostate during postnatal development. Prostate. 2001 May 15; 47(3):164-71. PMID: 11351345.
      Citations: 1     Fields:    Translation:Animals
    199. Izawa JI, Perrotte P, Greene GF, Scott S, Levy L, McGuire E, Madsen L, von Eschenbach AC, Pisters LL. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol. 2001 Mar; 165(3):867-70. PMID: 11176488.
      Citations: 7     Fields:    Translation:Humans
    200. Izawa JI, Ajam K, McGuire E, Scott S, von Eschenbach AC, Skibber J, Pisters LL. Major surgery to manage definitively severe complications of salvage cryotherapy for prostate cancer. J Urol. 2000 Dec; 164(6):1978-81. PMID: 11061895.
      Citations: 5     Fields:    Translation:Humans
    201. Pisters LL, Westney OL, Scott S, Swanson DA, Wood CG, Von Eschenbach AC, Dinney CP, McGuire EJ. Pubourethral sling simultaneous with radical retropubic prostatectomy for patients at high risk for postprostatectomy incontinence. Prostate Cancer Prostatic Dis. 2000 Dec; 3(S1):S34. PMID: 12497142.
      Citations:    Fields:    
    202. Pisters LL, English SF, Scott SM, Westney OL, Dinney CP, McGuire EJ. Salvage prostatectomy with continent catheterizable urinary reconstruction: a novel approach to recurrent prostate cancer after radiation therapy. J Urol. 2000 Jun; 163(6):1771-4. PMID: 10799179.
      Citations: 7     Fields:    Translation:Humans
    203. Sweeney P, Pisters LL. Ad5CMVp53 gene therapy for locally advanced prostate cancer--where do we stand? World J Urol. 2000 Apr; 18(2):121-4. PMID: 10854146.
      Citations: 4     Fields:    Translation:HumansCells
    204. Pettaway CA, Pisters LL, Troncoso P, Slaton J, Finn L, Kamoi K, Logothetis CJ. Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results. J Clin Oncol. 2000 Mar; 18(5):1050-7. PMID: 10694556.
      Citations: 23     Fields:    Translation:HumansCTClinical Trials
    205. Corral DA, Varma DG, Jackson EF, Amato RJ, Donat SM, Pisters LL. Magnetic resonance imaging and magnetic resonance angiography before postchemotherapy retroperitoneal lymph node dissection. Urology. 2000 Feb; 55(2):262-6. PMID: 10688091.
      Citations: 2     Fields:    Translation:Humans
    206. Perrotte P, Tran J, McGuire EJ, Pisters LL. Effect of prior therapy on survival after salvage cryotherapy for recurrent prostate cancer. Prostate Cancer Prostatic Dis. 1999 Nov; 2(S3):S25. PMID: 12496804.
      Citations: 1     Fields:    
    207. Pisters LL, Pettaway CA, Hossan E, Evans R, Steiner MS, Wood CG, Troncoso P, McDonnell TJ, Fenstenmacher MJ, Logothetis CJ. Intraprostatic AD-p53 gene therapy followed by radical prostatectomy: feasibility and preliminary results. Prostate Cancer Prostatic Dis. 1999 Nov; 2(S3):S27. PMID: 12496806.
      Citations: 1     Fields:    
    208. Donat SM, Slaton JW, Pisters LL, Swanson DA. Early nasogastric tube removal combined with metoclopramide after radical cystectomy and urinary diversion. J Urol. 1999 Nov; 162(5):1599-602. PMID: 10524876.
      Citations: 10     Fields:    Translation:HumansCTClinical Trials
    209. Pisters LL, Perrotte P, Scott SM, Greene GF, von Eschenbach AC. Patient selection for salvage cryotherapy for locally recurrent prostate cancer after radiation therapy. J Clin Oncol. 1999 Aug; 17(8):2514-20. PMID: 10561317.
      Citations: 9     Fields:    Translation:Humans
    210. Perrotte P, Litwin MS, McGuire EJ, Scott SM, von Eschenbach AC, Pisters LL. Quality of life after salvage cryotherapy: the impact of treatment parameters. J Urol. 1999 Aug; 162(2):398-402. PMID: 10411046.
      Citations: 8     Fields:    Translation:Humans
    211. Levy DA, Cromeens DM, Evans R, Stephens LC, von Eschenbach AC, Pisters LL. Transrectal ultrasound-guided intraprostatic injection of absolute ethanol with and without carmustine: a feasibility study in the canine model. Urology. 1999 Jun; 53(6):1245-51. PMID: 10367863.
      Citations: 2     Fields:    Translation:Animals
    212. Pisters LL. The challenge of locally advanced prostate cancer. Semin Oncol. 1999 Apr; 26(2):202-16. PMID: 10597731.
      Citations: 6     Fields:    Translation:Humans
    213. Pisters LL, Dinney CP, Pettaway CA, Scott SM, Babaian RJ, von Eschenbach AC, Troncoso P. A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer. J Urol. 1999 Feb; 161(2):509-14. PMID: 9915437.
      Citations: 9     Fields:    Translation:HumansCTClinical Trials
    214. Navone NM, Labate ME, Troncoso P, Pisters LL, Conti CJ, von Eschenbach AC, Logothetis CJ. p53 mutations in prostate cancer bone metastases suggest that selected p53 mutants in the primary site define foci with metastatic potential. J Urol. 1999 Jan; 161(1):304-8. PMID: 10037428.
      Citations: 21     Fields:    Translation:Humans
    215. Greene GF, Pisters LL, Scott SM, Von Eschenbach AC. Predictive value of prostate specific antigen nadir after salvage cryotherapy. J Urol. 1998 Jul; 160(1):86-90. PMID: 9628611.
      Citations: 5     Fields:    Translation:Humans
    216. Pisters LL, Troncoso P, Navone N. Prolonged survival with metastatic prostate cancer to bone. J Urol. 1998 Jun; 159(6):2100. PMID: 9598540.
      Citations:    Fields:    Translation:Humans
    217. Westney OL, Pisters LL, Pettaway CA, Tu SM, Pollack A, Dinney CP. Presentation, methods of diagnosis and therapy for pelvic recurrence following radical cystectomy for transitional cell carcinoma of the bladder. J Urol. 1998 Mar; 159(3):792-5. PMID: 9474150.
      Citations: 10     Fields:    Translation:Humans
    218. English SF, Pisters LL, McGuire EJ. The use of the appendix as a continent catheterizable stoma. J Urol. 1998 Mar; 159(3):747-9. PMID: 9474139.
      Citations: 1     Fields:    Translation:Humans
    219. Slaton JW, Balbay MD, Levy DA, Pisters LL, Nesbitt JC, Swanson DA, Dinney CP. Nephrectomy and vena caval thrombectomy in patients with metastatic renal cell carcinoma. Urology. 1997 Nov; 50(5):673-7. PMID: 9372873.
      Citations: 13     Fields:    Translation:HumansCells
    220. Pisters LL, el-Naggar AK, Luo W, Malpica A, Lin SH. C-met proto-oncogene expression in benign and malignant human renal tissues. J Urol. 1997 Sep; 158(3 Pt 1):724-8. PMID: 9258068.
      Citations: 15     Fields:    Translation:Humans
    221. Nesbitt JC, Soltero ER, Dinney CP, Walsh GL, Schrump DS, Swanson DA, Pisters LL, Willis KD, Putnam JB. Surgical management of renal cell carcinoma with inferior vena cava tumor thrombus. Ann Thorac Surg. 1997 Jun; 63(6):1592-600. PMID: 9205155.
      Citations: 47     Fields:    Translation:HumansCellsCTClinical Trials
    222. Chen ME, Pisters LL, Malpica A, Pettaway CA, Dinney CP. Risk of urethral, vaginal and cervical involvement in patients undergoing radical cystectomy for bladder cancer: results of a contemporary cystectomy series from M. D. Anderson Cancer Center. J Urol. 1997 Jun; 157(6):2120-3. PMID: 9146596.
      Citations: 15     Fields:    Translation:Humans
    223. Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, Babaian RJ. The efficacy and complications of salvage cryotherapy of the prostate. J Urol. 1997 Mar; 157(3):921-5. PMID: 9072600.
      Citations: 26     Fields:    Translation:HumansCTClinical Trials
    224. McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer. J Urol. 1997 Feb; 157(2):569-74. PMID: 8996359.
      Citations: 18     Fields:    Translation:Humans
    225. Cespedes RD, Pisters LL, von Eschenbach AC, McGuire EJ. Long-term followup of incontinence and obstruction after salvage cryosurgical ablation of the prostate: results in 143 patients. J Urol. 1997 Jan; 157(1):237-40. PMID: 8976261.
      Citations: 11     Fields:    Translation:Humans
    226. Corral DA, Pisters LL, von Eschenbach AC. Treatment options for localized recurrence of prostate cancer following radiation therapy. Urol Clin North Am. 1996 Nov; 23(4):677-84. PMID: 8948420.
      Citations: 2     Fields:    Translation:Humans
    227. Seigne JD, Pisters LL, von Eschenbach AC. Osteitis pubis as a complication of prostate cryotherapy. J Urol. 1996 Jul; 156(1):182. PMID: 8648793.
      Citations: 3     Fields:    Translation:Humans
    228. Sarosdy MF, Pisters LL, Carroll PR, Benson MC, Moon TD, Lamm DL, Hudson MA, Lerner SP, Koch MO, Schellhammer PF. Bropirimine immunotherapy of upper urinary tract carcinoma in situ. Urology. 1996 Jul; 48(1):28-32. PMID: 8693647.
      Citations: 2     Fields:    Translation:HumansCTClinical Trials
    229. Pisters LL, Westney L. The management of locally recurrent invasive bladder cancer following radical cystectomy. Semin Urol Oncol. 1996 May; 14(2):112-9. PMID: 8734739.
      Citations: 4     Fields:    Translation:Humans
    230. Pisters LL. Prostate cancer--adjusting the tiller. J Urol. 1996 May; 155(5):1678-80. PMID: 8627852.
      Citations:    Fields:    Translation:Humans
    231. Tanguay S, Pisters LL, Lawrence DD, Dinney CP. Therapy of locally recurrent renal cell carcinoma after nephrectomy. J Urol. 1996 Jan; 155(1):26-9. PMID: 7490850.
      Citations: 15     Fields:    Translation:Humans
    232. Delworth MG, Pisters LL, Fornage BD, von Eschenbach AC. Cryotherapy for renal cell carcinoma and angiomyolipoma. J Urol. 1996 Jan; 155(1):252-4; discussion 254-5. PMID: 7490847.
      Citations: 11     Fields:    Translation:Humans
    233. Pettaway CA, Pisters LL, Dinney CP, Jularbal F, Swanson DA, von Eschenbach AC, Ayala A. Sentinel lymph node dissection for penile carcinoma: the M. D. Anderson Cancer Center experience. J Urol. 1995 Dec; 154(6):1999-2003. PMID: 7500444.
      Citations: 24     Fields:    Translation:Humans
    234. Kagan J, Stein J, Babaian RJ, Joe YS, Pisters LL, Glassman AB, von Eschenbach AC, Troncoso P. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes. Oncogene. 1995 Nov 16; 11(10):2121-6. PMID: 7478532.
      Citations: 19     Fields:    Translation:HumansCells
    235. Pisters LL, Troncoso P, Zhau HE, Li W, von Eschenbach AC, Chung LW. c-met proto-oncogene expression in benign and malignant human prostate tissues. J Urol. 1995 Jul; 154(1):293-8. PMID: 7539865.
      Citations: 64     Fields:    Translation:Humans
    236. Kleinerman DI, Troncoso P, Lin SH, Pisters LL, Sherwood ER, Brooks T, von Eschenbach AC, Hsieh JT. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res. 1995 Mar 15; 55(6):1215-20. PMID: 7533659.
      Citations: 24     Fields:    Translation:Humans
    237. Kagan J, Pisters L, Troncoso P, Joe Y, Parat J, Babaian R, Voneschenbach A. Genetic instability in microsatellite sequences in prostate-cancer. Int J Oncol. 1994 Oct; 5(4):921-4. PMID: 21559661.
      Citations: 1     Fields:    
    238. Bandyk MG, Zhao L, Troncoso P, Pisters LL, Palmer JL, von Eschenbach AC, Chung LW, Liang JC. Trisomy 7: a potential cytogenetic marker of human prostate cancer progression. Genes Chromosomes Cancer. 1994 Jan; 9(1):19-27. PMID: 7507696.
      Citations: 10     Fields:    Translation:HumansCells
    239. Zhau HE, Pisters LL, Hall MC, Zhao LS, Troncoso P, Pollack A, Chung LW. Biomarkers associated with prostate cancer progression. J Cell Biochem Suppl. 1994; 19:208-16. PMID: 7529853.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    240. Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, von Eschenbach AC, Conti CJ. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma. J Natl Cancer Inst. 1993 Oct 20; 85(20):1657-69. PMID: 7692074.
      Citations: 74     Fields:    Translation:HumansCells
    241. Pisters LL, Wajsman Z. Use of predeposit autologous blood and intraoperative autotransfusion in urologic cancer surgery. Urology. 1992 Sep; 40(3):211-5. PMID: 1523742.
      Citations: 4     Fields:    Translation:Humans
    242. Pisters LL, Wajsman Z. A simple test for the detection of intraoperative rectal injury in major urological pelvic surgery. J Urol. 1992 Aug; 148(2 Pt 1):354. PMID: 1635133.
      Citations: 1     Fields:    Translation:Humans
    243. Pisters LL, Tykochinsky G, Wajsman Z. Intravesical bacillus Calmette-Guerin or mitomycin C in the treatment of carcinoma in situ of the bladder following prior pelvic radiation therapy. J Urol. 1991 Dec; 146(6):1514-7. PMID: 1942330.
      Citations: 4     Fields:    Translation:Humans
    244. Posttraumatic stress and depressive symptoms in renal cell carcinoma. Psycho-Oncology.
    245. Reply. Urology. 75:705-706.
    246. Neoadjuvant Systemic Therapy before Radical Prostatectomy in High-Risk Prostate Cancer Does Not Increase Surgical Morbidity. Clinical Genitourinary Cancer. 14:130-138.
    247. Sexual dysfunction in testicular cancer patients subjected to post-chemotherapy retroperitoneal lymph node dissection. Andrologia.
    248. Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation. Urologic Oncology: Seminars and Original Investigations. 33:166.e21-166.e29.
    249. Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer. Prostate Cancer and Prostatic Diseases. 18:276-280.
    250. Intratumoral heterogeneity. Cancer.
    251. A simplified protocol for evaluating and monitoring urethral stricture patients minimizes cost without compromising patient outcome. International Braz J Urol. 36:640.
    252. Clinical risk stratification in patients with surgically resectable micropapillary bladder cancer. BJU International.
    253. When prostate cancer remains undetectable. Turk Uroloji Dergisi. 41:32-38.
    254. The current status of gene therapy for prostate cancer. Cancer Control. 5:522-531.
    255. Intraprostatic AD-p53 gene therapy followed by radical prostatectomy. Prostate Cancer and Prostatic Diseases. 2.
    256. Genetic instability in microsatellite sequences in prostate cancer. International Journal of Oncology. 5:921-924.
    257. Results of salvage cryoablation of the prostate after radiation. Journal of Urology. 165:1941-1942.
    258. Rectal wall invasion of locally advanced prostate cancer. 637-640.
    259. Upper tract urothelial carcinoma topical issue 2016. World Journal of Urology. 1-12.
    260. Tissue Effects in a Randomized Controlled Trial of Short-term Finasteride in Early Prostate Cancer. EBioMedicine.
    261. Surgery for locally advanced disease. Current Prostate Reports. 4:59-66.
    262. Suprapubic prostatectomy for benign prostatic hyperplasia. 31-47.
    263. Considerations for patient selection for focal therapy. Therapeutic Advances in Urology. 5:330-337.
    264. Effect of prior therapy on survival after salvage cryotherapy for recurrent prostate cancer. Prostate Cancer and Prostatic Diseases. 2.
    265. Outcome of patients with clinically node-positive bladder cancer undergoing consolidative surgery after preoperative chemotherapy. Urologic Oncology: Seminars and Original Investigations. 34:59.e1-59.e8.
    266. Radiorekürren prostat kanseri için salvage terapiler. Turk Uroloji Dergisi. 37:350-356.
    267. Pubourethral sling simultaneous with radical retropubic prostatectomy for patients at high risk for postprostatectomy incontinence. Prostate Cancer and Prostatic Diseases. 3.
    268. Editorial Comment. Urology. 72:1314.
    269. Status of early prostate cancer detection. Cancer Bulletin. 45:389-396.
    270. Robotic-assisted laparoscopic versus open salvage radical prostatectomy following radiotherapy. Canadian Journal of Urology. 23:8271-8277.
    271. Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis. Oncotarget. 7:86280-86289.
    272. Examination of moderators of expressive writing in patients with renal cell carcinoma. Psycho-Oncology.
    273. Editorial comments. Journal of Urology. 166:1337-1338.
    274. The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer. World Journal of Surgical Oncology. 13.
    275. Transurethral resection with perioperative instillation of interferon-alpha or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer. Journal of Urology. 161:1135.
    276. Prostate cancer. 141-154.
    PISTERS's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (595)
    Explore
    _
    Co-Authors (113)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _